Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate for Postoperative Hypercoagulability in Gynecological Surgery
NCT06717490Recruiting
- Start
- Dec 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of magnesium sulfate in hypercoagulable state (2 arms). Primary endpoints: Clotting Time up to 6 hours, Clot Formation Time up to 6 hours and 2 more. Started Dec 2024; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
hypercoagulable state
Beyond the preview
Go deeper on NCT06717490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06717490.